Medicare Part B Patients - getting your
CONTOUR®NEXT products should never be difficult:

1

See your doctor for a CONTOUR®NEXT Portfolio Blood Glucose Meter and test strips prescription.

2

Choose the CONTOUR®NEXT Portfolio Blood Glucose Meter that works best for you.

CONTOUR®NEXT EZ

  • Proven accuracy1- shown to deliver results within ±10% of lab values
  • Large, easy-to-read display - ready to test right out of the box
  • Small blood sample
  • Second-Chance® sampling - gives patients 20 seconds to reapply blood to the same strip which may help prevent wasted strips3

CONTOUR®NEXT ONE

  • Remarkable accuracy2 - shown to deliver results within ±8.4% of lab values
  • Easy-to-read - display with smartLIGHT feature gives you instant feedback with colored target indicators
  • Small blood sample


WITHIN
TARGET
ABOVE
TARGET
BELOW
TARGET
  • Second-Chance® sampling - gives patients 60 seconds to reapply blood to the same strip which may help prevent wasted strips3

Remember, CONTOUR®NEXT Test Strips are always covered under Medicare Part B!*

3

Have your CONTOUR®NEXT Portfolio prescription filled at your pharmacy.

Need more help? Here are answers to some frequently asked questions about Medicare coverage:
 

Test strips are covered when medically necessary and prescribed by your physician. Medicare will reimburse either 80% of the Medicare Fee Schedule or the actual charges, whichever is less.

  • This means that once your annual Medicare "Part B" deductible is paid, you pay the other 20%. If you have supplemental or secondary insurance, you may pay even less than the 20%.
  • Many pharmacies, mail order and medical equipment suppliers will take care of all the Medicare paperwork and billing submissions for you.
  • Ask your pharmacist if this service is offered before you buy your CONTOUR® NEXT test strips.

More questions about Medicare?
Learn more about Medicare plans and coverage at: https://www.medicare.gov/pubs/pdf/11022-Medicare-Diabetes-Coverage.pdf.

CONTOUR® NEXT Test Strips

For non-insulin treated patients

  •   100 every 3 months

For insulin treated patients

  • 100 per month

Important note:
A doctor's prescription is required for Medicare reimbursement. If your doctor recommends that you test more often than Medicare's guidelines permit, your doctor may assist you in getting authorization from Medicare to receive more self-testing supplies which Medicare will cover after additional requirements are met. For more information, check with your doctor or see MLN Matters SE1008 for more info and use this link: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/SE1008.pdf

  • Your doctor must give you a prescription in order to obtain Medicare reimbursement.
  • Remember to ask your doctor to specify "Do Not Substitute" on the prescription to ensure that you receive the CONTOUR® NEXT brand.
  • Then, you can take your prescription to your local pharmacy, hospital or clinic pharmacy, medical equipment supplier, or Medicare mail order contract supplier.
  • You may want to call your chosen supplier to ensure that they sell CONTOUR® NEXT test strips and that they will assist you in filing your claim.

If you have any difficulty in obtaining your CONTOUR® NEXT test strips please call us (1-800-348-8100) 

and we will help you find a Medicare supplier who will provide you with CONTOUR® NEXT test strips.

To find a supplier that’s enrolled in Medicare, visit www.medicare.gov/supplier or call

1-800-MEDICARE (1-800-633-4227).




†10% applies to glucose levels ≥100 mg/dL. In multiple clinical trials examined by Bernstein et al., the CONTOUR®NEXT meter portfolio delivered at least 95% of results within 10% of the laboratory reference value for blood glucose concentrations ≥100 mg/dL and within ±10 mg/dL of the laboratory reference value for blood glucose concentrations <100 mg/dL.

‡ ±8.4% applies to values ≥100mg/dL. An ad hoc analysis demonstrated 95% of results fell within ±8.4 mg/dL or ±8.4% of the laboratory reference values for glucose concentrations <100 mg/dL or ≥100 mg/dL, respectively, when tested via subject-obtained capillary fingertip results (patients with diabetes).

*Not a guarantee of coverage and payment. Coverage and payment may be subject to co-insurance, deductible and patient eligibility requirements. Visit www.medicare.gov for more information.

References: 1. Bernstein, R. et al. A new test strip technology platform for self-monitoring of blood glucose. Journal of Diabetes Science and Technology. 2013; 7(5):1386-1399. 2. Christiansen, M. et al. A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology. 2017, Vol. 11(3) 567-573.3. Ascensia Diabetes Care. Data on File. Market Research, Hall & Partners, conducted online April/May 2015

The information brought to you by Ascensia Diabetes Care US Inc. provides general information and is not a guarantee of coverage or payment (partial or full), and is not intended as medical advice, diagnosis or treatment. Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures.

©2019 Ascensia Diabetes Care US Inc. All rights reserved.